Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Burges

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Archives of Gynecology and Obstetrics|September 7, 2021
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in GermanyTill Kaltofen, Friederike Hagemann, Nadia Harbeck, et al.
International Journal of Molecular Sciences|March 6, 2021
Sirtuin 1 and Sirtuin 3 in Granulosa Cell TumorsNina Schmid, Kim-Gwendolyn Dietrich, Ignasi Forne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancerHans Dieplinger, Donna Pauler Ankerst, Alexander Burges, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapyAnca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
BMC Cancer|October 22, 2013
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implantsSabine Heublein, Katinka Grasse, Harald Hessel, et al.
Plos One|July 28, 2022
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomasLisa Hiepp, Doris Mayr, Kathrin Gärtner, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 4, 2014
Malnutrition and clinical outcome in gynecologic patientsLinda Hertlein, Angela Kirschenhofer, Sophie Fürst, et al.
Trials|July 12, 2017
The impact of phosphate-balanced crystalloid infusion on acid-base homeostasis (PALANCE study): study protocol for a randomized controlled trialJudith-Irina Pagel, Nikolai Hulde, Tobias Kammerer, et al.
Oncology Letters|September 21, 2017
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer onlyLinda Hertlein, Johanna Rath, Christine Zeder-Göss, et al.
Archives of Gynecology and Obstetrics|April 7, 2018
Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screeningLinda Hertlein, Christine Zeder-Göß, Sophie Fürst, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Archives of Gynecology and Obstetrics|September 7, 2021
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in GermanyTill Kaltofen, Friederike Hagemann, Nadia Harbeck, et al.
International Journal of Molecular Sciences|March 6, 2021
Sirtuin 1 and Sirtuin 3 in Granulosa Cell TumorsNina Schmid, Kim-Gwendolyn Dietrich, Ignasi Forne, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancerHans Dieplinger, Donna Pauler Ankerst, Alexander Burges, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapyAnca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, et al.
BMC Cancer|October 22, 2013
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implantsSabine Heublein, Katinka Grasse, Harald Hessel, et al.
Plos One|July 28, 2022
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomasLisa Hiepp, Doris Mayr, Kathrin Gärtner, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 4, 2014
Malnutrition and clinical outcome in gynecologic patientsLinda Hertlein, Angela Kirschenhofer, Sophie Fürst, et al.
Trials|July 12, 2017
The impact of phosphate-balanced crystalloid infusion on acid-base homeostasis (PALANCE study): study protocol for a randomized controlled trialJudith-Irina Pagel, Nikolai Hulde, Tobias Kammerer, et al.
Oncology Letters|September 21, 2017
Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer onlyLinda Hertlein, Johanna Rath, Christine Zeder-Göss, et al.
Archives of Gynecology and Obstetrics|April 7, 2018
Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screeningLinda Hertlein, Christine Zeder-Göß, Sophie Fürst, et al.
Pageof 12